Blood transfusions in athletes. Old dogmas, new tricks

Clinical Chemistry and Laboratory Medicine

Volumn 44, Issue 12, 2006, Pages 1395-1402

  Lippi, Giuseppe ^a,c,d   Banfi, Giuseppe ^b,c  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c Medicina di Laboratorio dello Sport   (Italy)

^d UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

Antidoping testing; Blood doping; Blood transfusion; Hemoglobin; Sports

Indexed keywords

BLOOD GROUP ANTIGEN; BLOOD SUBSTITUTE; ERYTHROPOIETIN; GENOMIC DNA; HEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN;

ATHLETE; BLOOD ANALYSIS; BLOOD AUTOTRANSFUSION; BLOOD SAMPLING; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; COMPETITION; DNA DETERMINATION; DONOR; DOPING; ERYTHROCYTE; FALSE POSITIVE RESULT; FLOW CYTOMETRY; GENE THERAPY; GENOTYPE; GRAFT RECIPIENT; HEALTH CARE POLICY; HEMOGLOBIN DETERMINATION; HIGH THROUGHPUT SCREENING; HUMAN; ISOELECTRIC FOCUSING; LABORATORY TEST; LAW ENFORCEMENT; PERFORMANCE; PHENOTYPE; PHLEBOTOMY; PHYSICAL STRESS; PRIORITY JOURNAL; RELIABILITY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVIEW; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SINGLE NUCLEOTIDE POLYMORPHISM; SINGLE STRAND CONFORMATION POLYMORPHISM; SPORTS MEDICINE;

BLOOD GROUP ANTIGENS; BLOOD TRANSFUSION; BLOOD TRANSFUSION, AUTOLOGOUS; DOPING IN SPORTS; ERYTHROCYTE TRANSFUSION; ERYTHROCYTES; ERYTHROPOIESIS; ERYTHROPOIETIN; HEMATOLOGIC TESTS; HEMOGLOBINS; HUMANS; SPORTS;

EID: 33845702152     PISSN: 14346621     EISSN: 14346621     Source Type: Journal    
DOI: 10.1515/CCLM.2006.262     Document Type: Review

References (67)

1. Prendergast HM, Bannen T, Erickson TB, Honore KR. The toxic torch of the modern Olympic Games. Vet Hum Toxicol 2003;45:97-102.
2. Lippi G, Franchini M, Salvagno GL, Guidi GC. Biochemistry, physiology, and complications of blood doping: facts and speculation. Crit Rev Clin Lab Sci 2006;43:349-91.
3. Williams MH, Wesseldine S, Somma T, Schuster R. The effect of induced erythrocythemia upon 5-mile treadmill run time. Med Sci Sports Exerc 1981;13:169-75.
4. Brien AJ, Simon TL. The effects of red blood cell infusion on 10-km race time. J Am Med Assoc 1987;257:2761-5.
5. Robertson RJ, Gilcher R, Metz KF, Skrinar GS, Allison TG, Bahnson HT, et al. Effect of induced erythrocythemia on hypoxia tolerance during exercise. J Appl Physiol 1982;53:490-5.
6. Buick FJ, Gledhill N, Froese AB, Spriet L, Meyers EC. Effect of induced erythrocythemia on aerobic work capacity. J Appl Physiol 1980;48:636-42.
7. Ekblom BT. Blood boosting and sport. Baillieres Best Pract Res Clin Endocrinol Metab 2000;14:89-98.
8. Berglund B, Hemmingson P. Effect of reinfusion of autologous blood on exercise performance in cross-country skiers. Int J Sports Med 1987;8:231-3.
9. Spriet LL, Gledhill N, Froese AB, Wilkes DL. Effect of graded erythrocythemia on cardiovascular and metabolic responses to exercise. J Appl Physiol 1986;61:1942-8.
10. Jones M, Tunstall Pedoe D. Blood doping: a literature review. Br J Sports Med 1989;23:84-8.
11. Leigh-Smith S. Blood boosting. Br J Sports Med 2004;38:99-101.
12. McCrory P. Pursuing the dream. Br J Sports Med 2004;38:665.
13. Ekblom B, Goldbarg AN, Gullbring B. Response to exercise after blood loss and reinfusion. J Appl Physiol 1972;33:175-80.
14. Klein HG. Blood transfusion and athletic games people play. N Engl J Med 1985;312:854-6.
15. Spivak JL. Erythropoietin use and abuse: when physiology and pharmacology collide. Adv Exp Med Biol 2001;502:207-24.
16. Stray-Gundersen J, Videman T, Penttila I, Lereim I. Abnormal hematologic profiles in elite cross-country skiers: blood doping or? Clin J Sport Med 2003;13:132-7.
17. D'Onofrio G, Zini G. Addendum to strategies to deter blood doping in sports. Haematologica 2002;87:ELT31.
18. Abellan R, Remacha AF, Ventura R, Sardà MP, Segura J, Rodriguez FA. Hematologic response to four weeks of intermittent hypobaric hypoxia in highly trained athletes. Haematologica 2005;90:126-7.
19. Rice L, Alfrey CP. The negative regulation of red cell mass by neocytolysis: physiologic and pathophysiologic manifestations. Cell Physiol Biochem 2005;15:245-50.
20. Berglund B, Girgegard G, Wide L, Philstedt P. Effects of blood transfusion on some haematological variables in endurance athletes, Med Sci Sports Exerc 1989;21:637-42.
21. Union Cycliste International. Puerto operation: The UCI's standpoint. Available at http://www.uci.ch/. Accessed 2 August 2006.
22. USA Today. Spanish scandal not limited to cycling. Available at http://www.usatoday.com. Accessed 2 August 2006.
23. Haisma HJ, de Hon O. Gene doping. Int J Sports Med 2006;27:257-66.
24. Robinson N, Giraud S, Saudan C, Baume N, Avois L, Mangin P, et al. Erythropoietin and blood doping. Br J Sports Med 2006;40(Suppl 1):30-4.
25. Parisotto R, Gore CJ, Emslie KR, Ashenden MJ, Brugnara C, Howe C, et al. A novel method utilising markers of altered erythropoiesis for the detection of recombinant human erythropoietin abuse in athletes. Haematologica 2000;85:564-72.
26. Cartron JP. Defining the Rh blood group antigens. Biochemistry and molecular genetics. Blood Rev 1994;8:199-212.
27. Nelson M, Ashenden M, Langshaw M, Popp H. Detection of homologous blood transfusion by flow cytometry: a deterrent against blood doping. Haematologica 2002;87:881-2.
28. Nelson M, Popp H, Sharpe K, Ashenden M. Proof of homologous blood transfusion through quantification of blood group antigens. Haematologica 2003;88:1284-95.
29. Wu YY, Csako G. Rapid and/or high-throughput genotyping for human red blood cell, platelet and leukocyte antigens, and forensic applications. Clin Chim Acta 2006;363:165-76.
30. Drexler C, Glock B, Vadon M, Staudacher E, Dauber EM, Ulrich S, et al. Tetragametic chimerism detected in a healthy woman with mixed-field agglutination reactions in ABO blood grouping. Transfusion 2005;45:698-703.
31. Avent ND, Reid ME. The Rh blood group system: a review. Blood 2000;95:375-87.
32. Flegel WA, Wagner FF, Müller TH, Gassner C. Rh phenotype prediction by DNA typing and its application to practice. Transfus Med 1998;8:281-302.
33. Montpetit A, Phillips MS, Mongrain I, Lemieux R, St-Louis M. High-throughput molecular profiling of blood donors for minor red blood cell and platelet antigens. Transfusion 2006;46:841-8.
34. Beiboer SH, Wieringa-Jelsma T, Maaskant-Van Wijk PA, van der Schoot CE, van Zwieten R, Roos D, et al. Rapid genotyping of blood group antigens by multiplex polymerase chain reaction and DNA microarray hybridization. Transfusion 2005;45:667-79.
35. Denomme GA, Van Oene M. High-throughput multiplex single-nucleotide polymorphism analysis for red cell and platelet antigen genotypes. Transfusion 2005;45:660-6.
36. Hashmi G, Shariff T, Seul M, Vissavajjhala P, Hue-Roye K, Charles-Pierre D, et al. A flexible array format for large-scale, rapid blood group DNA typing. Transfusion 2005;45:680-8.
37. Pellegrino J Jr, Castilho L, Rios M, De Souza CA. Blood group genotyping in a population of highly diverse ancestry. J Clin Lab Anal 2001;15:8-13.
38. Smith KJ, James DS, Hunt WC, McDonough W, Quintana R. A randomized, double-blind comparison of donor tolerance of 400 mL, 200 mL, and sham red cell donation. Transfusion 1996;36:674-80.
39. Starklint J, Norgaard Bech J, Aagaard O, Bjerregaard Pedersen E. Hypochromic reticulocytes, hypochromic erythrocytes and p-transferrin receptors in diagnosing iron-deficient erythropoiesis. Scand J Clin Lab Invest 2004;64:691-702.
40. Damsgaard R, Munch T, Morkeberg J, Mortensen SP, Gonzalez-Alonso J. Effects of blood withdrawal and reinfusion on biomarkers of erythropoiesis in humans: implications for anti-doping strategies. Haematologica 2006;91:1006-8.
41. Berglund B, Hemmingsson P, Birgegard G. Detection of autologous blood transfusions in cross-country skiers. Int J Sports Med 1987;8:66-70.
42. Guidi GC, Lippi G, Solero GP, Poli G, Plebani M. Managing transferability of laboratory data. Clin Chim Acta 2006. In press; doi:10.1016/j.cca.2006.06. 009.
43. Fraser CG, Wilkinson SP, Neville RG, Knox JD, King JF, Mac Walter RS. Biologic variation of common hematologic laboratory quantities in the elderly. Am J Clin Pathol 1989;92:464-70.
44. Banfi G, Mauri C, Morelli B, Di Gaetano N, Malgeri U, Melegati G. Reticulocyte count, mean reticulocyte volume, immature reticulocyte fraction, and mean sphered cell volume in elite athletes: reference values and comparison with the general population. Clin Chem Lab Med 2006;44:616-22.
45. Malcovati L, Pascutto C, Cazzola M. Hematologic passport for athletes competing in endurance sports: a feasibility study. Haematologica 2003;88:570-1.
46. Ashenden MJ, Lacoste A, Orhant E, Audran M, Sharpe K. Longitudinal variation of hemoglobin and reticulocytes in elite rowers. Haematologica 2004;89:1403-4.
47. Sharpe K, Ashenden MJ, Schumacher YO. A third generation approach to detect erythropoietin abuse in athletes. Haematologica 2006;91:356-63.
48. Ashenden MJ, Sharpe K, Schoch C, Schumacher YO. Effect of pre-competition and altitude training on blood models used to detect erythropoietin abuse by athletes. Haematologica 2004;89:1019-20.
49. Ekblom B, Holmberg HC, Eriksson K. Doping in endurance sports. Survey of individual [Hb] levels can expose doping. Lakartidningen 2001;98:5490-2.
50. Banfi G, Dolci A, Zorzino L, Longhi E, Barberis M. Comparison of 3 automatic systems for reticulocytes counts during an ultraendurance mountain marathon. J Sports Med Phys Fitness 2003;43:256-7.
51. Ashenden MJ, Sharpe K, Damsgaard R, Jarvis L. Standardization of reticulocyte values in an antidoping context. Am J Clin Pathol 2004;121:816-25.
52. Costongs GM, Janson PC, Bas BM, Hermans J, Brombacher PJ, Van Wersch JW. Short-term and long-term intraindividual variations and critical difference of haematological laboratory parameters. J Clin Chem Clin Biochem 1985;23:69-76.
53. Schumacher YO, Jankovits R, Bultermann D, Schmid A, Berg A. Hematological indices in elite cyclists. Scand J Med Sci Sports 2002;12:301-8.
54. Schumacher YO, Grathwohl D, Barturen JM, Wollenweber M, Heinrich L, Schmid A, et al. Haemoglobin, haematocrit and red blood cell indices in elite cyclists. Are the control values for blood testing valid? Int J Sports Med 2000;21:380-5.
55. Lippi G, Franchini M, Guidi G. Haematocrit measurement and antidoping policies. Clin Lab Haematol 2002;24:65-6.
56. Banfi G, Del Fabbro M, Mauri C, Corsi MM, Melegati G. Haematological parameters in elite rugby players during a competitive season. Clin Lab Haematol 2006;28:183-8.
57. Lippi G, Guidi GC, Mattiuzzi C, Plebani M. Preanalytical variability: the dark side of the moon in laboratory testing. Clin Chem Lab Med 2006;44:358-65.
58. Lippi G, Salvagno GL, Montagnana M, Franchini M, Guidi GC. Phlebotomy issues and quality improvement in results of laboratory testing. Clin Lab 2006;52:217-30.
59. Banfi G, Dolci A. Preanalytical phase of sport biochemistry and haematology. J Sports Med Phys Fitness 2003;43:223-30.
60. Lippi G, Franchini M, Guidi GC. Haematological testing and antidoping policies. Int J Sports Med 2005;26:508-9.
61. Lippi G, Salvagno GL, Solero GP, Franchini M, Guidi GC. Stability of blood cell counts, hematologic parameters and reticulocytes indexes on the Advia A120 hematologic analyzer. J Lab Clin Med 2005;146:333-40.
62. Lippi G, Salvagno GL, Solero GP, Guidi GC. The influence of the tourniquet time on hematological testing for antidoping purposes. Int J Sports Med 2006;27:359-62.
63. Sandler SG, Yu H, Rassai N. Risks of blood transfusion and their prevention. Clin Adv Hematol Oncol 2003;1:307-13.
64. Ghaphery NA. Performance-enhancing drugs. Orthop Clin North Am 1995;26:433-42.
65. Smith DA, Perry PJ. The efficacy of ergogenic agents in athletic competition. Part II. Other performance-enhancing agents. Ann Pharmacother 1992;26:653-9.
66. Gauthier J. Blood doping and cardiovascular consequences. Presse Med 2002;31:1904-8.
67. Lippi G, Franchini M, Guidi G. Second generation blood tests to detect erythropoietin abuse by athletes: effective but not preventive? Haematologica 2004;89:ELT05.